Connect with us

Medical Marijuana

Lone Star State Takes Step Forward On Medical Cannabis

Published

on

Lone Star State Takes Step Forward On Medical Cannabis

The Texas Department of Public Safety (DPS) has published new recommendations for 139 entrants seeking a license for issuing an organization under the state’s merciful program. On August 8, DPS outlined an additional application process that all existing applicants must complete by September 15 to remain registered. The changes follow in the adoption of the 46 home bill, which expands the access of patients to cannabis with low TGC levels and introduces healthcare regions to improve coverage across the country. Applicants now have to submit updated stories in detail about operational plans, coverage strategies across the country, financial documentation and priorities in the election of the regions. The region 7, which includes Austin, is without restriction due to the presence of existing licensees, while the Dallas and Houston regions will receive two licenses.

DPS noted that at least nine licenses will be awarded on December 1 through the competitiveness process, and the assessment is evenly weighing in security plans and infrastructure, accountability measures, financial liability and technical abilities. Applicants can also update the details of the real estate control and the site, refer to the expanded qualifications within the HB 46, as well as strengthen the disclosure of financial capabilities to reflect the readiness to start a vertically integrated operation within the 24-month operational period. The signed confirmation form must also be included in the submission.

In addition to the current pool, DPS Will Accept New Applications Until Sept. 15 For Three September Licenses That Must Be Awarded In 2026. Unsuccessful Applicants From the Current Process Will Automatically Be Considered For These Future Licenses Highest-Ranking Applicants not Selected in 2025. DPS Will also Establish A Waitlist of Backup Candidates, Which IT DRAW from IF A SELECTED License Fails to meet Operational terms.

The proposed rules, which are now subject to public commentary through the Texas Register, note a significant shift in how Texas manages the licensing process of medical cannabis. With a greater emphasis on the access of patients across the country, financial stability and prompt readiness, it is expected that the process of competitive assessment of the state will be very carefully studied, as the applicants position themselves to one of the limited licenses.

Message The most stellar state makes a step forward over medical cannabis appeared first further Retail Marijuana Retail Report – News and Information for Cannabis sellers.

(Tagstotranslate) medical marijuana (T) Texas

Idaho

Marijuana Retail Report

Published

on

By

Marijuana Retail Report


News




Minidoka County Clerk Tonya Page simply chose not to count them




WordPress › Error

Continue Reading

CSA

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



The case will be heard from June 29 to July 15

The Drug Enforcement Administration is beginning hearings on a proposal to reclassify recreational cannabis under federal drug law. DEA medical cannabis has been transferred in FDA-approved drugs and from state-licensed operators in April, marking the most significant change in US cannabis policy in half a century.

The DEA hearing, scheduled for June 29-July 15, is to consider the agency’s May 21 proposal to move hemp from Schedule I of the federal Controlled Substances Act (CSA) to Schedule III. Such a step would have a significant influence on a regulated adult cannabis industry that would be exempt from punitive tax policies for businesses that sell Schedule I drugs.

Cannabis reform advocates fear exclusion from hearings

Because transfer proposal established by the DEA, the agency will act as an advocate for reform through hearings. As a result, only individuals and groups opposed to relocation will be allowed to testify, which has made many cannabis reform advocates skeptical of the process.

The National Marijuana Law Reform Organization attempted to testify at the hearing arguing that hemp should be excluded from the CSA entirely.

“Marijuana cannot legally remain in Schedule I,” said Joseph A. Bondi, chairman of NORML’s board of directors. statement from the Cannabis Policy Reform Advocacy Group. “But Schedule III is not the end of the road. It is, at most, an interim fix. It does not address the federal government’s failure to recognize legal cannabis users of legal age under state law.”

To read the rest of this article on Forbes, Click here

Continue Reading

Glass House

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



The company previously announced plans to separate adult and medical use

After set script, another public cannabis operator separated its medical marijuana from adult marijuana in an attempt to go public on the New York Stock Exchange.

But California-based vertically integrated operator Glass House Brands said in documents filed Thursday that it plans to go further than listing on the NYSE. In particular, the company stated that it is preparing for export and interstate trade.

The company previously said in a press release on Wednesday that it had applied to list on the NYSE after “unbundling” its medical and adult businesses.

If successful, Glass House would become the second U.S. cannabis company to go public on a major U.S. exchange, following Florida-based multi-state marijuana operator Trulieve Cannabis Corp.

To read the rest of this article on MJ Biz Daily, Click here

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media